CVS Health Corp. buy tamam
Summary
This prediction ended on 05.11.21 with a price of €81.52. With a performance of 37.16% the BUY prediction by tamam was a big success. Dividends of €6.72 are taken into consideration when calculating the performance. tamam has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CVS Health Corp. | -2.901% | -2.901% | -7.339% | 1.468% |
iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
Comments by tamam for this prediction
In the thread CVS Health Corp. diskutieren
tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
tamam stimmt am 29.06.2018 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.In the thread Trading CVS Health Corp.